✦ LIBER ✦

United States regulatory considerations for intrauterine progestins for hormone replacement therapy

✍ Scribed by Lisa Rarick

Book ID: 116381564
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 90 KB
Volume: 75
Category: Article
ISSN: 0010-7824
DOI: 10.1016/j.contraception.2006.12.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and Potency of Progesti

Pharmacokinetics and Potency of Progestins used for Hormone Replacement Therapy and Contraception

✍ Frank Z. Stanczyk 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 499 KB

WATER BALANCE IN THE BRATTLEBORO RAT: CO

WATER BALANCE IN THE BRATTLEBORO RAT: CONSIDERATIONS FOR HORMONE REPLACEMENT THERAPY

✍ Lewis B. Kinter 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 757 KB

Comparison of hormonal activity (estroge

Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy

✍ V Beck; E Unterrieder; L Krenn; W Kubelka; A Jungbauer 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

[ACS Symposium Series] Natural Products

[ACS Symposium Series] Natural Products for Pest Management Volume 927 || Regulatory Considerations for Researchers of Natural Products in the United States

✍ Rimando, Agnes M.; Duke, Stephen O. 📂 Article 📅 2006 🏛 American Chemical Society ⚖ 1001 KB

Dosing patterns for continuous renal rep

Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States

✍ Ramesh Venkataraman; John A. Kellum; Paul Palevsky 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 604 KB

Variation in initial kidney replacement

Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States

✍ Amy Devlin; Sushrut S. Waikar; Daniel H. Solomon; Bing Lu; Tamara Shaykevich; Gr 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 104 KB 👁 2 views

## Abstract ## Objective Little is known about the patterns of use of initial kidney replacement therapies among patients with lupus nephritis (LN) end‐stage renal disease (ESRD). We aimed to identify sociodemographic and clinical factors associated with variation in initial kidney replacement the